Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431 · see citing works

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683 · see citing works

The neurobiology of zinc in health and disease

Frederickson, C. J., Koh, J., & Bush, A. I. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1671 · Cited by 1,841 · see citing works

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · see citing works

The metallobiology of Alzheimer's disease

Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315 · see citing works

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,200 · see citing works

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · see citing works

Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression

Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885 · see citing works

Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death

Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 708 · see citing works

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620 · see citing works

Activation and redistribution of c‐Jun N‐terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease

Zhu, X.-W., Raina, A., Rottkamp, C., Aliev, G., Perry, G., Boux, H., & Smith, M. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00046.x · Cited by 440 · see citing works

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1–40).

Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · see citing works

Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Aβ production in APP23 transgenic mice

Bayer, T. A., Schäfer, S., Simons, A., Kemmling, A., Kamer, T., Tepest, R., Eckert, A., Schüssel, K., Eikenberg, O., Sturchler, C., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332818100 · Cited by 325 · see citing works

Clioquinol, a Drug for Alzheimer's Disease Specifically Interfering with Brain Metal Metabolism:  Structural Characterization of Its Zinc(II) and Copper(II) Complexes

Di Vaira, M., Bazzicalupi, C., Orioli, P., Messori, L., Bruni, B., & Zatta, P. (2004) · Inorganic Chemistry · doi:10.1021/ic0494051 · Cited by 292 · see citing works

Anticancer Activity of the Antibiotic Clioquinol

Ding, W., Liu, B., Vaught, J. L., Yamauchi, H., & Lind, S. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3577 · Cited by 248 · see citing works

Neutral endopeptidase can hydrolyze β-amyloid(1–40) but shows no effect on β-amyloid precursor protein metabolism

Howell, S. W., Nalbantoglu, J. N., & Crine, P. (1995) · Peptides · doi:10.1016/0196-9781(95)00021-b · Cited by 204 · see citing works

In vivo reduction of amyloid-β by a mutant copper transporter

Phinney, A. L., Drisaldi, B., Schmidt, S. D., Lugowski, S. J., Coronado, V. A., Liang, Y., Horne, P., Yang, J., Sekoulidis, J., Coomaraswamy, J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2332851100 · Cited by 201 · see citing works

Genetic Deletion of Glycogen Synthase Kinase-3β Abrogates Activation of IκBα Kinase, JNK, Akt, and p44/p42 MAPK but Potentiates Apoptosis Induced by Tumor Necrosis Factor

Takada, Y., Fang, X., Jamaluddin, M. S., Boyd, D. D., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403449200 · Cited by 182 · see citing works

Role of matrix metalloproteinases in melanoma cell invasion

Hofmann, U. B., Houben, R., Bröcker, E., & Becker, J. C. (2005) · Biochimie · doi:10.1016/j.biochi.2005.01.013 · Cited by 177 · see citing works

Role of protein kinase B in Alzheimer's neurofibrillary pathology

Pei, J.-J., Khatoon, S., An, W., Nordlinder, M., Tanaka, T., Braak, H., Tsujio, I., Takeda, M., Alafuzoff, I. I., Winblad, B. G., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0657-y · Cited by 165 · see citing works

Copper Ions Strongly Activate the Phosphoinositide-3-Kinase/Akt Pathway Independent of the Generation of Reactive Oxygen Species

Ostrakhovitch, E. A., Lordnejad, M. R., Schliess, F., Sies, H., & Klotz, L. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2559 · Cited by 152 · see citing works

Clioquinol Mediates Copper Uptake and Counteracts Copper Efflux Activities of the Amyloid Precursor Protein of Alzheimer's Disease

Treiber, C., Simons, A., Strauß, M., Hafner, M., Cappai, R., Bayer, T. A., & Multhaup, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407410200 · Cited by 147 · see citing works

Proteolysis of Aβ Peptide from Alzheimer Disease Brain by Gelatinase A

Roher, A. E., Kasunic, T. C., Woods, A. S., Cotter, R. J., Ball, M. J., & Fridman, R. A. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2872 · Cited by 136 · see citing works

Inhibition of human gingival gelatinases (MMP-2 and MMP-9) by metal salts

de Souza, A. P., Gerlach, R. F., & Line, S. R. P. (2000) · Dental Materials · doi:10.1016/s0109-5641(99)00084-6 · Cited by 136 · see citing works

Phosphorylation Is Involved in the Activation of Metal-regulatory Transcription Factor 1 in Response to Metal Ions

LaRochelle, O., Gagné, V., Charron, J., Soh, J., & Séguin, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108313200 · Cited by 121 · see citing works

Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas

Kubiatowski, T., Jang, T., Lachyankar, M. B., Salmonsen, R. A., Nabi, R. R., Quesenberry, P. J., Litofsky, N. S., Ross, A. H., & Recht, L. D. (2001) · Journal of neurosurgery · doi:10.3171/jns.2001.95.3.0480 · Cited by 113 · see citing works

Proteolysis of AA Amyloid Fibril Proteins by Matrix Metalloproteinases-1, -2, and -3

Stix, B., Kähne, T., Sletten, K., Raynes, J. G., Roessner, A., & Röcken, C. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61727-0 · Cited by 105 · see citing works

Balancing function vs. self defense: The CNS as an active regulator of immune responses

Carson, M. J., & Sutcliffe, J. G. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990101)55:1 · Cited by 99 · see citing works

Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons

Shimoke, K., Yamagishi, S., Yamada, M., Ikeuchi, T., & Hatanaka, H. (1999) · Developmental Brain Research · doi:10.1016/s0165-3806(98)00172-2 · Cited by 71 · see citing works

Neurotoxicity from glutathione depletion is dependent on extracellular trace copper

White, A. R., & Cappai, R. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10537 · Cited by 66 · see citing works

Metal-protein attenuating compounds and Alzheimer’s disease

Ritchie, C. W., Bush, A. I., & Masters, C. L. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.12.1585 · Cited by 62 · see citing works

The oxidative neurotoxicity of clioquinol

Benvenisti‐Zarom, L., Chen, J., & Regan, R. F. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.04.023 · Cited by 58 · see citing works

Activation of protein kinase C betaII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin.

Miyata, Y., Sato, T., Yano, M., & Itô, A. (2004) · PubMed · Cited by 56 · see citing works

GAL4/UAS-WGA system as a powerful tool for tracingDrosophila transsynaptic neural pathways

Tabuchi, K., Sawamoto, K., Suzuki, E., Ozaki, K., Sone, M., Hama, C., Morimoto-Tanifuji, T., Yuasa, Y., Yoshihara, Y., Nose, A., et al. (2000) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(20000101)59:1 · Cited by 51 · see citing works

PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells

Li, J., Chen, H., Tang, M., Shi, X.-L., Amin, S., Desai, D., Costa, M., & Huang, C.-S. (2004) · Journal of Cell Biology · doi:10.1083/jcb.20040100420090708c · Cited by 50 · see citing works

Glycogen Synthase Kinase 3β Is a Negative Regulator of Growth Factor-induced Activation of the c-Jun N-terminal Kinase

Liu, S., Yu, S., Hasegawa, Y., LaPushin, R., Xu, H., Woodgett, J. R., Mills, G. B., & Fang, X. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408607200 · Cited by 47 · see citing works

In vitro gamma‐secretase cleavage of the Alzheimer's amyloid precursor protein correlates to a subset of presenilin complexes and is inhibited by zinc

Hoke, D. E., Tan, J., Ilaya, N. T., Culvenor, J. G., Smith, S. J., White, A. R., Masters, C. L., & Evin, G. M. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04950.x · Cited by 46 · see citing works

Heparin-Binding Epidermal Growth Factor Cleavage Mediates Zinc-Induced Epidermal Growth Factor Receptor Phosphorylation

Wu, W., Samet, J. M., Silbajoris, R. A., Dailey, L. A., Sheppard, D., Bromberg, P. A., & Graves, L. M. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0233oc · Cited by 42 · see citing works

Induction of matrix metalloproteinase-2 by tenascin-X deficiency is mediated through the c-Jun N-terminal kinase and protein tyrosine kinase phosphorylation pathway.

Matsumoto, K.-I., Minamitani, T., Orba, Y., Sato, M., Sawa, H., & Ariga, H. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.03.041 · Cited by 30 · see citing works

DIFFERENTIAL PRODUCTION OF METALLOPROTEINASES AFTER INSTILLING VARIOUS URBAN AIR PARTICLE SAMPLES TO RAT LUNG

Adamson, I. Y. R., Vincent, R., & Bakowska, J. (2003) · Experimental Lung Research · doi:10.1080/01902140303753 · Cited by 24 · see citing works

Determination of chinoform in biological fluids and nervous tissues of the dog by gas chromatography-mass spectrometry

Matsuki, Y., Ito, T., Fukuhara, K., Abe, M., Othaki, T., & Nambara, T. (1987) · Archives of Toxicology · doi:10.1007/bf00295093 · Cited by 13 · see citing works

Effect of oxidation of β‐amyloid precursor protein on its β‐secretase cleavage. A model study with synthetic peptides and candidate β‐secretases

Rpaea‐Kozik, M., Kozik, A., & Travis, J. W. (1998) · Journal of Peptide Research · doi:10.1111/j.1399-3011.1998.tb01246.x · Cited by 7 · see citing works

PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells

Li, J., Chen, H., Tang, M., Shi, X.-L., Amin, S., Desai, D., Costa, M., & Huang, C.-S. (2004) · Journal of Cell Biology · doi:10.1083/jcb.200401004 · Cited by 4 · see citing works

Alzheimer’s disease: Clinical trials and drug development

Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · see citing works

Targeting Free Radicals in Oxidative Stress-Related Human Diseases

Poprac, P., Jomova, K., Simunkova, M., Kollar, V., Rhodes, C. J., & Valko, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.005 · Cited by 1,107 · see citing works

Metals, oxidative stress and neurodegenerative disorders

Jomová, K., Vondráková, D., Lawson, M. K., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,053 · see citing works

Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

Rempe, R. G., Hartz, A. M. S., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 784 · see citing works

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672 · see citing works

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · see citing works

Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis

Bush, A. I., & Tanzi, R. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.001 · Cited by 566 · see citing works

Amyloid <i>β</i> -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526 · see citing works

Metabolism and functions of copper in brain

Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 511 · see citing works

Copper in the brain and Alzheimer’s disease

Hung, Y. H., Bush, A. I., & Cherny, R. A. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0600-y · Cited by 496 · see citing works

8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications

Prachayasittikul, V., Prachayasittikul, V., Prachayasittikul, S., & Ruchirawat, S. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s49763 · Cited by 451 · see citing works

Metal dyshomeostasis and oxidative stress in Alzheimer’s disease

Greenough, M. A., Camakaris, J., & Bush, A. I. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 439 · see citing works

The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases

Cauwe, B., den Steen, P. E. V., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 384 · see citing works

Alzheimer's disease, metal ions and metal homeostatic therapy

Zatta, P., Drago, D., Bolognin, S., & Sensi, S. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.002 · Cited by 369 · see citing works

Metallostasis in Alzheimer's disease

Ayton, S., Lei, P., & Bush, A. I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 354 · see citing works

Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332 · see citing works

Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals

Paterson, B. M., & Donnelly, P. S. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00215a · Cited by 296 · see citing works

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease

Toledo, E. M., & Inestrosa, N. C. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.72 · Cited by 290 · see citing works

Copper complexes as therapeutic agents

Duncan, C., & White, A. R. (2011) · Metallomics · doi:10.1039/c2mt00174h · Cited by 293 · see citing works

Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease

Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 288 · see citing works

8-Hydroxyquinolines in medicinal chemistry: A structural perspective

Oliveri, V., & Vecchio, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.007 · Cited by 282 · see citing works

Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics

Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 281 · see citing works

Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation

Crouch, P. J., Hung, L. W., Adlard, P. A., Cortés, M., Lal, V., Filiz, G., Perez, K. A., Nurjono, M., Caragounis, A., Du, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809057106 · Cited by 280 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes

Zuroff, L. R., Daley, D. A., Black, K. L., & Koronyo‐Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 275 · see citing works

Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes

Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K. A., Barnham, K. J., Masters, C. L., & Hill, A. F. (2008) · The FASEB Journal · doi:10.1096/fj.07-9357com · Cited by 253 · see citing works

Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease

McColl, G., Roberts, B., Pukala, T., Kenche, V., Roberts, C., Link, C., Ryan, T., Masters, C., Barnham, K., Bush, A., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-57 · Cited by 256 · see citing works

The transition metals copper and iron in neurodegenerative diseases

Rivera-Mancía, S., Pérez‐Neri, I., Rı́os, C., Tristán-López, L. A., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 243 · see citing works

Interactions of Zn(ii) and Cu(ii) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity

Tõugu, V., Tiiman, A., & Palumaa, P. (2011) · Metallomics · doi:10.1039/c0mt00073f · Cited by 222 · see citing works

Melatonin in Alzheimer’s Disease

Li, L., Qiong-xia, H., Yang, S.-S., Chu, J., Wang, J., & Tian, Q. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714575 · Cited by 216 · see citing works

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205 · see citing works

Copper as a key regulator of cell signalling pathways

Grubman, A., & White, A. R. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.11 · Cited by 199 · see citing works

Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide

Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q., Masters, C. L., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705957200 · Cited by 196 · see citing works

Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation

Kim, W. S., Rahmanto, A. S., Kamili, A., Rye, K.-A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., & Garner, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607831200 · Cited by 191 · see citing works

Ceria/POMs hybrid nanoparticles as a mimicking metallopeptidase for treatment of neurotoxicity of amyloid-β peptide

Guan, Y., Li, M., Dong, K., Gao, N., Ren, J., Zheng, Y.-C., & Qu, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.005 · Cited by 191 · see citing works

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 192 · see citing works

Are amyloid‐degrading enzymes viable therapeutic targets in Alzheimer’s disease?

Nalivaeva, N., Beckett, C. S., Belyaev, N. D., & Turner, A. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07510.x · Cited by 178 · see citing works

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction

Corona, C., Masciopinto, F., Silvestri, E., Viscovo, A. D., Lattanzio, R., Sorda, R. L., Ciavardelli, D., Goglia, F., Piantelli, M., Canzoniero, L. M. T., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.73 · Cited by 189 · see citing works

Insights into Zn2+ homeostasis in neurons from experimental and modeling studies

Colvin, R. A., Bush, A. I., Volitakis, I., Fontaine, C. P., Thomas, D. G., Kikuchi, K., & Holmes, W. R. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00541.2007 · Cited by 188 · see citing works

Copper and Alzheimer's disease

Donnelly, P. S., Xiao, Z., & Wedd, A. G. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.01.678 · Cited by 185 · see citing works

The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity

Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07402.x · Cited by 183 · see citing works

Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators

Tõugu, V., Karafin, A., Zovo, K., Chung, R. S., Howells, C., West, A. K., & Palumaa, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06269.x · Cited by 181 · see citing works

Biomedical applications of copper ionophores

Oliveri, V. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213474 · Cited by 171 · see citing works

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease

Grimm, M. O. W., Mett, J., Stahlmann, C. P., Haupenthal, V. J., Zimmer, V. C., & Hartmann, T. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00098 · Cited by 159 · see citing works

Metal Ion Physiopathology in Neurodegenerative Disorders

Bolognin, S., Luigi Messori, A., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 157 · see citing works

Copper deficiency and neurological disorders in man and animals

Zatta, P. F., & Frank, A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.10.001 · Cited by 157 · see citing works

Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid

Altschul, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R., & Bush, A. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.012 · Cited by 154 · see citing works

Alzheimer’s disease: How metal ions define β-amyloid function

Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 151 · see citing works

Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury

Hamada, T., Fondevila, C., Busuttil, R. W., & Coito, A. J. (2007) · Hepatology · doi:10.1002/hep.21922 · Cited by 147 · see citing works

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

Ijaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 146 · see citing works

Alzheimer's disease & metals: therapeutic opportunities

Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 144 · see citing works

Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model

Zhao, L., Wang, J., Wang, Y.-R., & Fa, X.-Z. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.019 · Cited by 140 · see citing works

Metal ionophores – An emerging class of anticancer drugs

Ding, W., & Lind, S. E. (2009) · IUBMB Life · doi:10.1002/iub.253 · Cited by 138 · see citing works

Strategies for the Inhibition of Protein Aggregation in Human Diseases

Bartolini, M., & Andrisano, V. (2010) · ChemBioChem · doi:10.1002/cbic.200900666 · Cited by 136 · see citing works

Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics

Davies, K. M., Mercer, J. F. B., Chen, N., & Double, K. L. (2016) · Clinical Science · doi:10.1042/cs20150153 · Cited by 134 · see citing works

ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro

Chan, S. L., Kim, W. S., Kwok, J. B., Hill, A. F., Cappai, R., Rye, K., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05433.x · Cited by 133 · see citing works

The role of copper ions in pathophysiology and fluorescent sensors for the detection thereof

Verwilst, P., Sunwoo, K., & Kim, J. S. (2015) · Chemical Communications · doi:10.1039/c4cc10366a · Cited by 130 · see citing works

Clioquinol Decreases Amyloid-β Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease

Grossi, C., Francese, S., Casini, A., Rosi, M. C., Luccarini, I., Fiorentini, A., Gabbiani, C., Luigi Messori, A., Moneti, G., & Casamenti, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1063 · Cited by 130 · see citing works

Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation

Kauwe, J. S. K., Bailey, M. H., Ridge, P. G., Perry, R., Wadsworth, M. E., Hoyt, K. L., Staley, L. A., Karch, C. M., Harari, O., Cruchaga, C., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004758 · Cited by 125 · see citing works

Methionine-35 of A <i>β</i> (1–42): Importance for Oxidative Stress in Alzheimer Disease

Butterfield, D. A., & Sultana, R. (2011) · Journal of Amino Acids · doi:10.4061/2011/198430 · Cited by 124 · see citing works

Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease

Crouch, P. J., & Barnham, K. J. (2012) · Accounts of Chemical Research · doi:10.1021/ar300074t · Cited by 125 · see citing works

Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation

Xiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.003 · Cited by 122 · see citing works

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development

Sumter, T. F., Xian, L., Huso, T. H., Koo, M., Chang, Y.-T., Almasri, T. N., Chia, L., Inglis, C., Reid, D., & Resar, L. M. S. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160316152147 · Cited by 120 · see citing works

Role of matrix metalloproteinase-3 in neurodegeneration

Kim, E., & Hwang, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07082.x · Cited by 114 · see citing works

Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function

Oudbier, S. J., Goh, J., Looijaard, S. M. L. M., Reijnierse, E. M., Meskers, C. G. M., & Maier, A. B. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac121 · Cited by 119 · see citing works

Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency

Stoltenberg, M., Bush, A. I., Bach, G., Smidt, K., Larsen, A., Rungby, J., Lund, S. A., Doering, P., & Danscher, G. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.025 · Cited by 114 · see citing works

Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders

Rivera, S., García‐González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 112 · see citing works

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

Horstmann, S., Budig, L., Gardner, H., Koziol, J. A., Deuschle, M., Schilling, C., & Wagner, S. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000827 · Cited by 111 · see citing works

Copper and Alzheimer’s Disease

Mathys, Z. K., & White, A. R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_10 · Cited by 112 · see citing works

Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity

Cappai, R., & Barnham, K. J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9469-8 · Cited by 108 · see citing works

Pharmacological activity of metal binding agents that alter copper bioavailability

Helsel, M. E., & Franz, K. J. (2015) · Dalton Transactions · doi:10.1039/c5dt00634a · Cited by 107 · see citing works

Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease

Davies, D. A., Adlimoghaddam, A., & Albensi, B. C. (2021) · Cells · doi:10.3390/cells10081884 · Cited by 111 · see citing works

Small molecule inhibitors of Aβ‐aggregation and neurotoxicity

Hawkes, C. A., Ng, V., & McLaurin, J. (2009) · Drug Development Research · doi:10.1002/ddr.20290 · Cited by 103 · see citing works

Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy

Zheng, H., Youdim, M. B. H., & Fridkin, M. (2010) · ACS Chemical Biology · doi:10.1021/cb900264w · Cited by 99 · see citing works

Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K+ current inhibition mediated by activation of caspases and GSK-3

Scala, F., Fusco, S., Ripoli, C., Piacentini, R., Puma, D. D. L., Spinelli, M., Laezza, F., Grassi, C., & D’Ascenzo, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.034 · Cited by 96 · see citing works

Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges

Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00352 · Cited by 94 · see citing works

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

Drew, S. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00317 · Cited by 93 · see citing works

Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery

Vilella, A., Belletti, D., Sauer, A. K., Hagmeyer, S., Sarowar, T., Masoni, M., Stasiak, N., Mulvihill, J. J., Ruozi, B., Forni, F., et al. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.12.006 · Cited by 92 · see citing works

8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation

Gomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 92 · see citing works

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy

Gaur, K., Vázquez-Salgado, A. M., Duran-Camacho, G., Dominguez-Martinez, I., Benjamín-Rivera, J. A., Fernández-Vega, L., Carmona‐Sarabia, L., García, A. C., Pérez-Deliz, F., Román, J. A. M., et al. (2018) · Inorganics · doi:10.3390/inorganics6040126 · Cited by 91 · see citing works

Zinc and Central Nervous System Disorders

Wang, B., Fang, T., & Chen, H. (2023) · Nutrients · doi:10.3390/nu15092140 · Cited by 93 · see citing works

Autophagy: A cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically

Bergamini, E. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.001 · Cited by 89 · see citing works

The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions

Tiiman, A., Palumaa, P., & Tõugu, V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.023 · Cited by 88 · see citing works

Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation

Crouch, P. J., Tew, D. J., Du, T., Nguyen, D., Caragounis, A., Filiz, G., Blake, R. E., Trounce, I. A., Soon, C. P. W., Laughton, K. M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05870.x · Cited by 88 · see citing works

Intracellular copper deficiency increases amyloid-β secretion by diverse mechanisms

Cater, M. A., McInnes, K. T., Li, Q., Volitakis, I., Fontaine, S. L., Mercer, J. F. B., & Bush, A. I. (2008) · Biochemical Journal · doi:10.1042/bj20080103 · Cited by 86 · see citing works

ECM in brain aging and dementia

Morawski, M., Filippov, M., Tzinia, A., Tsilibary, E., & Vargova, L. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00010-4 · Cited by 84 · see citing works

The AβCs of Aβ-cleaving Proteases

Leissring, M. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800022200 · Cited by 84 · see citing works

Bis (thiosemicarbazonato) Cu-64 Complexes for Positron Emission Tomography Imaging of Alzheimer's Disease

Fodero‐Tavoletti, M. T., Villemagne, V. L., Paterson, B. M., White, A. R., Li, Q., Camakaris, J., O'Keefe, G. J., Cappai, R., Barnham, K. J., & Donnelly, P. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1359 · Cited by 83 · see citing works

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain

Kupershmidt, L., Weinreb, O., Amit, T., Mandel, S. A., Bar‐Am, O., & Youdim, M. B. H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.040 · Cited by 80 · see citing works

Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 65 · see citing works

Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy

Ferrada, E., Arancibia, V., Bárbara Loeb, L., Norambuena, E., Olea‐Azar, C., & Huidobro-Toro, J. P. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.02.004 · Cited by 81 · see citing works

Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities

Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 79 · see citing works

Metals in alzheimer's disease: a systemic perspective

Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 79 · see citing works

PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease

Cherny, R. A., Ayton, S., Finkelstein, D. I., Bush, A. I., McColl, G., & Massa, S. M. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-120029 · Cited by 78 · see citing works

Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming

Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77 · see citing works

The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer's disease

Crouch, P., White, A., & Bush, A. I. (2007) · The FEBS Journal · doi:10.1111/j.1742-4658.2007.05918.x · Cited by 81 · see citing works

Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy

Love, S. (2009) · Frontiers in bioscience · doi:10.2741/3567 · Cited by 75 · see citing works

Aspects of β-Amyloid as a Biomarker for Alzheimer's Disease

Andréasson, U., Portelius, E., Andersson, M. E., Blennow, K., & Zetterberg, H. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.59 · Cited by 74 · see citing works

The role of GSK3 in Alzheimer disease

Hernández, F., de Barreda, E. G., Fuster-Matanzo, A., Goñi‐Oliver, P., Lucas, J. J., & Ávila, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.05.017 · Cited by 73 · see citing works

Stabilization of Nontoxic Aβ-Oligomers: Insights into the Mechanism of Action of Hydroxyquinolines in Alzheimer's Disease

Ryan, T. M., Roberts, B. R., McColl, G., Hare, D. J., Doble, P., Li, Q., Lind, M., Roberts, A. M., Mertens, H. D. T., Kirby, N. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2912-14.2015 · Cited by 72 · see citing works

Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands

Caragounis, A., Du, T., Filiz, G., Laughton, K. M., Volitakis, I., Sharples, R. A., Cherny, R. A., Masters, C. L., Drew, S. C., Hill, A. F., et al. (2007) · Biochemical Journal · doi:10.1042/bj20070579 · Cited by 61 · see citing works

Clioquinol induces metal-dependent degradation of the Alzheimer's disease amyloid beta peptide by up-regulation of matrix metalloproteases

White, A., Du, T., Laughton, K., Volitakis, I., Sharples, R., Hoke, D., Holsinger, R. M. D., Evin, G. M., Cherny, R., Hill, A. F., et al. (2006) · Journal of Neurochemistry

MMP-7 cleaves amyloid β fragment peptides and copper ion inhibits the degradation

Taniguchi, M., Matsuura, K., Nakamura, R., Kojima, A., Konishi, M., & Akizawa, T. (2017) · Biometals · doi:10.1007/s10534-017-0048-4 · Cited by 20 · see citing works

The role of metals in modulating metalloprotease activity in the AD brain

Filiz, G., Price, K. A., Caragounis, A., Du, T., Crouch, P. J., & White, A. R. (2008) · European Biophysics Journal · doi:10.1007/s00249-007-0244-1 · Cited by 40 · see citing works

Therapeutic Treatment of Alzheimer's Disease Using Metal Complexing Agents

Price, K. A., Crouch, P. J., & White, A. R. (2010) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805159511001010106